Latest News for HNSA.ST
/PRNewswire/ -- Hansa Biopharma AB, "Hansa" or the "Company" (NASDAQ STOCKHOLM: HNSA), today published its Annual and Sustainability Reports for 2025. Peter
/PRNewswire/ -- Hansa Biopharma AB, "Hansa" or the "Company" (NASDAQ STOCKHOLM: HNSA), today published its Annual and Sustainability Reports for 2025. Peter
/PRNewswire/ -- Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced that the Food and Drug Administration (FDA) has
/PRNewswire/ -- Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced that the Food and Drug Administration (FDA) has
/PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), today announced its Q4 2025 and full-year financial results. Renée Aguiar-Lucander, CEO,
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for HNSA.ST.
Senate Trading
No Senate trades found for HNSA.ST.
U.S. House Trading
No House trades found for HNSA.ST.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.